
INFevo announces over RMB 100M in pre-A funding for cell models and research platforms (opens in a new tab)
INFevo discloses a pre-A round exceeding RMB 100 million for model R&D, research products and team development. The report describes OCOO-T's experimental metrics and platform plans; results apply to the stated datasets and tasks, not clinical efficacy.








